{"id":"W4241096387","doi":"10.3324/haematol.2013.092155","title":"Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I","year":2013,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":162,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Incyte","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Hazard ratio; Placebo; Internal medicine; Randomized controlled trial; Confidence interval; Janus kinase 2; Myeloproliferative neoplasm; Anemia; Surgery; Gastroenterology; Bone marrow; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004015876,0.0006721283,0.001699403,0.0003628218,0.0004724073,0.0006937251,0.0003933352,0.0009785574,0.001043108],"category_scores_gemma":[0.002662144,0.000303019,0.001915991,0.0004388947,0.0004230147,0.0006721814,0.0004000815,0.001095585,0.0002407941],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006641709,"about_ca_system_score_gemma":0.0005059552,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004984504,"about_ca_topic_score_gemma":0.0008084871,"domain_scores_codex":[0.9988559,0.0005402936,0.0001089977,0.0001868168,0.0001492524,0.0001587933],"domain_scores_gemma":[0.9978249,0.0004586642,0.0008588823,0.0001900504,0.0001646122,0.0005028867],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7172984,0.008357245,0.1759624,0.0005467067,0.003982007,0.0003974652,0.000307566,0.002097656,0.01036126,0.00009484605,0.001189374,0.07940511],"study_design_scores_gemma":[0.08317186,0.2712513,0.6327778,0.00009152976,0.003992002,0.0005583772,0.0001432485,0.001907914,0.003766167,0.0001766737,0.00206632,0.00009676722],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964812,0.002416633,0.0001720207,0.00007837568,0.00001735463,0.00009205647,0.0003376982,0.00001301545,0.0003916237],"genre_scores_gemma":[0.99809,0.0003475529,0.0001673628,0.0001182647,0.00005296323,0.00009887842,0.0009266927,0.000002223685,0.0001961387],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004015876,"threshold_uncertainty_score":0.02123827,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01293538303997603,"score_gpt":0.2314839646634885,"score_spread":0.2185485816235125,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}